Oscar Health (NYSE:OSCR) Director Vanessa Ames Wittman Sells 25,000 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) Director Vanessa Ames Wittman sold 25,000 shares of the stock in a transaction on Friday, September 18th. The shares were sold at an average price of $32.24, for a total transaction of $806,000.00. Following the transaction, the director directly owned 112,121 shares in the company, valued at approximately $3,614,781.04. The trade was a 18.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oscar Health Price Performance

OSCR stock traded down $0.64 during trading on Tuesday, hitting $30.65. The stock had a trading volume of 8,238,111 shares, compared to its average volume of 7,024,898. The company’s 50-day moving average price is $30.75 and its two-hundred day moving average price is $24.22. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $34.48. The stock has a market capitalization of $9.46 billion, a P/E ratio of 21.89, a PEG ratio of 0.37 and a beta of 2.37. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. During the same period in the previous year, the company posted ($0.89) earnings per share. The business’s revenue was up 70.4% on a year-over-year basis. As a group, research analysts predict that Oscar Health, Inc. will post 1.74 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on OSCR shares. Barclays increased their target price on shares of Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a research report on Thursday, September 17th. Bank of America lifted their price objective on Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a research report on Thursday, September 17th. Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $34.00 price target on shares of Oscar Health in a report on Thursday, September 17th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Oscar Health has a consensus rating of “Hold” and an average price target of $33.90.

Institutional Trading of Oscar Health

Several institutional investors and hedge funds have recently bought and sold shares of OSCR. Geode Capital Management LLC boosted its position in shares of Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock worth $68,964,000 after buying an additional 116,430 shares during the period. BIT Capital GmbH raised its holdings in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after buying an additional 5,227,152 shares during the period. Simplify Asset Management Inc. acquired a new position in Oscar Health during the 4th quarter worth about $2,948,000. Convergence Investment Partners LLC acquired a new position in Oscar Health during the 1st quarter worth about $1,208,000. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in Oscar Health during the 1st quarter valued at about $1,297,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.